Literature DB >> 25432811

Treatment of leprosy.

Hemanta Kumar Kar1, Ruchi Gupta2.   

Abstract

Leprosy is a curable disease, having been eliminated from many countries, including India. This has been possible due to the wide availability of effective and safe drugs. Treatment of leprosy has undergone considerable changes over decades, from chaulmoogra oil in 1915 to dapsone monotherapy in 1946, then eventually to multidrug therapy (MDT) in 1982. In the last two decades, reports of resistance to all first-line drugs have appeared in the literature, with the need to conduct clinical trials using newer but highly bactericidal drugs and their combinations against Mycobacterium leprae.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25432811     DOI: 10.1016/j.clindermatol.2014.07.007

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN: 0738-081X            Impact factor:   3.541


  11 in total

1.  Stability of Dapsone in Extemporaneously Compounded Oral Suspensions.

Authors:  Hugo Alarie; M Mihaela Friciu; Grégoire Leclair
Journal:  Can J Hosp Pharm       Date:  2018-04-30

2.  Profile of Defaulters and Pattern of Treatment Default among Leprosy Patients at a Tertiary Care Hospital: A 10-Year Analysis.

Authors:  Sabha Mushtaq; Devraj Dogra; Nafis Faizi; Naina Dogra
Journal:  Indian Dermatol Online J       Date:  2020-05-10

3.  DDS promotes longevity through a microbiome-mediated starvation signal.

Authors:  Haeri Choi; Sung Chun Cho; Young Wan Ha; Billie Ocampo; Shirley Park; Shiwen Chen; Christopher F Bennett; Jeehae Han; Ryan Rossner; Jong-Sun Kang; Yun-Ll Lee; Sang Chul Park; Matt Kaeberlein
Journal:  Transl Med Aging       Date:  2019-07-03

4.  Design and statistical modeling of mannose-decorated dapsone-containing nanoparticles as a strategy of targeting intestinal M-cells.

Authors:  Alexandre Cc Vieira; Luíse L Chaves; Marina Pinheiro; Domingos Ferreira; Bruno Sarmento; Salette Reis
Journal:  Int J Nanomedicine       Date:  2016-06-03

5.  International open trial of uniform multidrug therapy regimen for leprosy patients: Findings & implications for national leprosy programmes.

Authors:  Ponnaiah Manickam; Sanjay M Mehendale; Bathyala Nagaraju; Kiran Katoch; Abdul Jamesh; Ramalingam Kutaiyan; Shen Jianping; Shivakumar Mugudalabetta; Vitthal Jadhav; Prabu Rajkumar; Jayasree Padma; Kanagasabai Kaliaperumal; Vijayakumar Pannikar; Padabettu Krishnamurthy; Mohan D Gupte
Journal:  Indian J Med Res       Date:  2016-10       Impact factor: 2.375

6.  Evaluation of safety tool for ambulatory leprosy patients at risk of adverse outcome.

Authors:  Cara MacRae; Swana Kopalakrishnan; Lena Faust; Michael Klowak; Adrienne Showler; Stefanie A Klowak; Andrea K Boggild
Journal:  Trop Dis Travel Med Vaccines       Date:  2018-03-02

7.  Chemotherapeutic efficacies of a clofazimine and diminazene aceturate combination against piroplasm parasites and their AT-rich DNA-binding activity on Babesia bovis.

Authors:  Bumduuren Tuvshintulga; Mahmoud AbouLaila; Thillaiampalam Sivakumar; Dickson Stuart Tayebwa; Sambuu Gantuya; Khandsuren Naranbaatar; Aki Ishiyama; Masato Iwatsuki; Kazuhiko Otoguro; Satoshi Ōmura; Mohamad Alaa Terkawi; Azirwan Guswanto; Mohamed Abdo Rizk; Naoaki Yokoyama; Ikuo Igarashi
Journal:  Sci Rep       Date:  2017-10-24       Impact factor: 4.379

Review 8.  The immunology of other mycobacteria: M. ulcerans, M. leprae.

Authors:  Katharina Röltgen; Gerd Pluschke; John Stewart Spencer; Patrick Joseph Brennan; Charlotte Avanzi
Journal:  Semin Immunopathol       Date:  2020-02-25       Impact factor: 9.623

9.  Case Report: Rifampicin-Induced Thrombocytopenia in a Patient with Borderline Lepromatous Leprosy.

Authors:  Tiejun Shui; Chao Shi; Zhichun Jing; Degang Yang; Jianyu Zhu
Journal:  Am J Trop Med Hyg       Date:  2020-10       Impact factor: 3.707

10.  World Health Organization (WHO) antibiotic regimen against other regimens for the treatment of leprosy: a systematic review and meta-analysis.

Authors:  Maria Lazo-Porras; Gabriela J Prutsky; Patricia Barrionuevo; Jose Carlos Tapia; Cesar Ugarte-Gil; Oscar J Ponce; Ana Acuña-Villaorduña; Juan Pablo Domecq; Celso De la Cruz-Luque; Larry J Prokop; Germán Málaga
Journal:  BMC Infect Dis       Date:  2020-01-20       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.